Therapy of Chronic Cold Agglutinin Disease With Eculizumab

计划入组 13 人 · 首次发布于 2011 年 2 月 25 日

Cold Agglutinin Disease Real World Evidence Registry

计划入组 429 人 · 首次发布于 2023 年 3 月 30 日

Zanubrutinib in Primary Cold Agglutinin Disease

计划入组 25 人 · 首次发布于 2023 年 10 月 4 日

Sutimlimab(Enjaymo)

Tylend Cold

Cold 'n Cough

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

Real-World Safety Data Confirms Long-Term Tolerability of ENJAYMO in Cold Agglutinin Disease Patients

Low-Dose Rituximab Trial Shows Limited Efficacy in Cold Agglutinin Disease Patients

Recordati Rare Diseases Presents Nine Research Studies on Rare Hematologic Disorders at ASH 2025